Skip to main content
Clinical Trials/NCT02306200
NCT02306200
Recruiting
Not Applicable

Cardiovascular Health Improvement Project

University of Michigan1 site in 1 country9,999 target enrollmentAugust 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Aneurysm
Sponsor
University of Michigan
Enrollment
9999
Locations
1
Primary Endpoint
Establishing a biobank of patients with Aortic Disease
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Detailed Description

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls. The aims of the study are to collect biological specimens (blood, plasma, serum, aortic tissue) and family history; establish a biobank, establish a comprehensive database with information from consented patients, and provide researchers with high quality well annotated DNA samples with demographic and clinical information.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
August 2053
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marion Hofmann Bowman

Associate Professor of Internal Medicine

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Any patient over the age of 18 who is able/willing to give informed consent
  • Patients \<18 years of age with parental consent and assent (if assent is applicable for their age)
  • Diagnosis of:
  • aortic pathology potentially due to a known or suspected inherited condition
  • Idiopathic aortic aneurysm
  • Interesting of novel vascular pathology in the aorta or main branches
  • Family history of aortic or vascular disease
  • Other cardiovascular disease
  • Healthy controls with no apparent cardiovascular disease

Exclusion Criteria

  • Not willing or able to sign the consent

Outcomes

Primary Outcomes

Establishing a biobank of patients with Aortic Disease

Time Frame: 40 years

Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease

Study Sites (1)

Loading locations...

Similar Trials